equaline triple antibiotic (Supervalu Inc)
Welcome to the PulseAid listing for the equaline triple antibiotic drug offered from Supervalu Inc. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Supervalu Inc |
| NON-PROPRIETARY NAME: | bacitracin, neomycin, polymyxin B |
| SUBSTANCE NAME: | BACITRACIN; NEOMYCIN SULFATE; POLYMYXIN B SULFATE |
| TYPE: | HUMAN OTC DRUG |
| PHARMA CLASS: | |
| ROUTE: | TOPICAL |
| DOSAGE FORM: | OINTMENT |
| MARKETING CATEGORY NAME: | OTC MONOGRAPH FINAL |
| START MARKETING DATE: | 2014-03-28 |
| END MARKETING DATE: | 0000-00-00 |
equaline triple antibiotic HUMAN OTC DRUG Details:
| Item Description | equaline triple antibiotic from Supervalu Inc |
| LABELER NAME: | Supervalu Inc |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 400; 3.5; 5000([USP’U]/g; mg/g; [USP’U]/g) |
| START MARKETING DATE: | 2014-03-28 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 41163-067_58ff1e78-5690-48ac-93ee-774604bbf73d |
| PRODUCT NDC: | 41163-067 |
| APPLICATION NUMBER: | part333B |
Other BACITRACIN; NEOMYCIN SULFATE; POLYMYXIN B SULFATE Pharmaceutical Manufacturers / Labelers:
